Singulus Technologies (SNG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
29 Jul, 2026Executive summary
Revenue for 2025 was €48.3 million, a significant decline from €75.9 million in 2024, mainly due to delays in major contracts across all segments and subdued customer investment amid global economic uncertainty.
EBIT dropped to -€11.7 million from -€0.7 million in the prior year, reflecting underutilization of capacity and persistent fixed costs.
Net loss for 2025 was €-14.2 million, compared to €-5.4 million in 2024.
A strategic partnership and new €29 million financing agreement were secured in March 2026, expected to improve future liquidity and earnings.
Financial highlights
Gross margin declined to 29.0% from 33.6% year-over-year, mainly due to lower business volume.
Operating expenses were €25.7 million, slightly down from €26.2 million in 2024.
Research and development expenses increased to €6.0 million (2024: €4.8 million).
Cash and cash equivalents at year-end were €6.2 million, down from €11.3 million.
Order intake was €33.4 million (2024: €77.2 million); order backlog at year-end was €62.5 million (2024: €77.4 million).
Outlook and guidance
Revenue for 2026 is expected to rise to approximately €83 million, with positive EBIT in the low single-digit millions, driven by the Solar and Semiconductor segments.
Revenue distribution in 2026 is projected at a 2:1:1 ratio across Solar, Semiconductor, and Life Science.
2027 is forecasted to see further revenue growth and continued positive EBIT.
Latest events from Singulus Technologies
- Q1-2026 delivered robust revenue and EBIT growth, with 2026 sales set to surge on Solar strength.SNG
Q1 202629 Jul 2026 - 2024 revenue grew, but EBIT stayed negative; outlook hinges on new orders and liquidity.SNG
Q4 202429 Jul 2026 - Order intake doubled and gross margin rose, but sales guidance was cut amid ongoing risks.SNG
Q2 202429 Jul 2026 - Revenue and orders fell, but margin improved; outlook positive amid ongoing risks.SNG
Q1 202529 Jul 2026 - Sales, EBIT, and order intake rose, but liquidity and going concern risks remain.SNG
Q3 202429 Jul 2026 - Revenue and orders fell sharply, resulting in losses and heightened liquidity risks.SNG
Q2 202529 Jul 2026 - Sales, EBIT, and order intake fell sharply; refinancing is critical by mid-2026.SNG
Q3 202529 Jul 2026